-

William Blair Expands Biopharma Investment Banking Group With Senior Hire

CHICAGO--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, today announced the addition of Terence Tan as managing director in the firm’s Healthcare investment banking team. Based in New York, Tan will focus on providing biopharma companies with comprehensive advisory services.

“It is my pleasure to welcome Terence to William Blair’s Healthcare investment banking practice and its biopharma group,” said Steve Tole, head of Healthcare investment banking at William Blair. “Our team of committed bankers provides strategic investors and financial sponsors with unique sector expertise and tailored advisory services across the fast-paced biopharma industry, including its various complex subsectors, and Terence’s addition will further deepen our capabilities and commitment to our clients.”

Tan brings more than 19 years of experience in biopharma investment banking, serving companies across all stages of development. He joins from Cantor Fitzgerald, where he served as a managing director focused on providing biopharma companies with investment banking guidance, including debt, equity, and equity-linked securities, private placements, and mergers and acquisitions. Tan has worked closely with venture capital firms, hedge funds, and mutual funds to unlock sophisticated financing solutions, having also held roles with Jefferies and UBS. He received his B.S. from Cornell University.

“William Blair is well-known for its premier investment banking platform, thoughtful client service, and innovative solutions to leading biopharma companies,” Tan said. “I am thrilled to join such a well-respected team and to deliver outstanding outcomes for our clients.”

About William Blair Investment Banking

William Blair’s investment banking group enables corporations, financial sponsors, and owner/entrepreneurs around the world to achieve their growth, liquidity, and financing objectives. Drawing on the collective intellectual capital and deep sector expertise of a global team that reaches over 20 cities on four continents, the investment banking group brings a rigorous and innovative approach to corporate board advisory projects, mergers and acquisitions, and equity and debt financing. From January 2020 to December 2024, the team advised on more than $810 billion in completed transaction volume.

About William Blair

William Blair is the premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*

*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.

William Blair


Release Summary
Terence Tan Joins William Blair's Biopharma Investment Banking Group in New York
Release Versions

More News From William Blair

William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage

CHICAGO--(BUSINESS WIRE)--William Blair today announced that Alethia Young has initiated coverage of 13 biotechnology companies, marking the next step in the firm’s continued expansion of its biotech offering. Young joined William Blair in May 2026 as part of a broader investment in the firm’s equities platform. With 25 years of experience across biotechnology and healthcare, she brings a perspective shaped by roles on both Wall Street and within the industry, most recently as chief financial o...

C.J. Jaskoll Joins William Blair as Chief Technology Officer

CHICAGO--(BUSINESS WIRE)--William Blair today announced that C.J. Jaskoll has joined the firm as chief technology officer, leading William Blair’s firmwide strategy to leverage artificial intelligence, data analytics, and other advanced capabilities to empower growth, unlock innovation, and elevate the client experience. Jaskoll brings more than 25 years of experience in the investment industry and will focus on enabling our business's intellectual capital to deliver creative solutions aligned...

William Blair Expands Investment Banking Platform with Acquisition of Armentum Partners

CHICAGO--(BUSINESS WIRE)--William Blair today announced it has acquired Armentum Partners, a premier boutique debt and alternative capital solutions advisory firm serving venture-backed businesses, public companies, and academic institutions. The transaction marks William Blair’s second investment banking acquisition of the year and underscores the firm’s continued investment in key growth areas including healthcare, technology, and the venture capital ecosystem. It broadens William Blair’s cap...
Back to Newsroom